Skip to main content

Abstract

The “sphingolipidoses” constitute a group of heritable diseases involving storage of various glycosphingolipids mainly in the central nervous system.1 There are two major types of neural glycosphingolipids; cerebroside and its sulfate ester, sulfatide, are characteristic of white matter, and gangliosides are characteristic of gray matter. Storage of cerebrosides are found in Gaucher’s disease (glycosylceramide),2 Fabry’s disease (galactosylgalactosylglucosylceramide),3 Krabbe’s disease (galactosylceramide),4 lactosylceramide lipidosis,5 metachromatic leukodystrophy (galactosyl-3-sulfate ceramide),6 Niemann-Pick disease (phosphorylcholine ester of ceramide),7 and fucosidosis (tetra- and pentahexoside ceramide).8 There are six known gangliosidoses. Three of these, Tay-Sachs disease (TSD),9 late infantile lipidosis,10,11 and Sandhoff’s disease12 involve mainly storage of the GM2-ganglioside in brain tissue. Two others, Norman-Landing disease,13 or general gangliosidosis,14 and Derry’s disease,15 or juvenile gangliosidosis,14 result in an accumulation of the GM1-ganglioside in brain and other tissues. A disorder of ganglioside metabolism with storage of both GM2- and GM3-gangliosides has been reported in a single patient by Pilz et al.16

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stoffel, W., Sphingolipids, Annu. Rev. Biochem. 40: 57 (1971).

    PubMed  CAS  Google Scholar 

  2. Fredrickson, D. S. and Sloan, H. R., Glucosylceramide lipidoses. Gaucher’s disease, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 730–759 (1972).

    Google Scholar 

  3. Sweeley, C. C., Klionsky, B., Krivit, W., and Desnick, R. J., Fabry’s disease. Glycosphingolipid lipidosis, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 663–687 (1972).

    Google Scholar 

  4. Suzuki, K. and Suzuki, Y., Galactosyl ceramide lipidosis: Globoid cell leucodystrophy (Krabbe’s disease), in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 760–782 (1972).

    Google Scholar 

  5. Dawson, G., Matalon, R., and Stein, A. O., Lactosylceramidosis: Lactosylceramide galactosyl hydrolase deficiency and accumulation of lactosylceramide in cultured skin fibroblasts, J. Pediatr. 79: 423 (1971).

    PubMed  CAS  Google Scholar 

  6. Moser, H. W., Sulfatide lipidoses: Metachromatic leukodystrophy, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 688–729 (1972).

    Google Scholar 

  7. Fredrickson, D. S. and Sloan, H. R., Sphingomyelin lipidoses: Niemann-Pick disease, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 783–807 (1972).

    Google Scholar 

  8. Durand, P., Barrone, C., Delia Cella, G., and Philippart, M., Fucosidosis, Lancet 1: 1198 (1968).

    Google Scholar 

  9. Volk, B. W., Schneck, L., and Adachi, M., Clinic pathology and biochemistry of Tay-Sachs disease, in: Handbook of Clinical Neurology, P. J. Vinken, and G. W. Bruyn, eds., North-Holland, Amsterdam, Vol. 10, pp. 385–426 (1970).

    Google Scholar 

  10. Bernheimer, H. and Seiteiberger, F.: Über das Verhalten der Ganglioside im Gehirn bei 2 Fällen von spatinfantiler amaurotischer Idiotie. Wien Klin. Wochenschr. 80: 163 (1968).

    PubMed  CAS  Google Scholar 

  11. Volk, B. W., Adachi, M., Schneck, L., Saifer, A., and Kleinberg, W., G-5 variant of systemic late infantile lipidosis, Arch. Pathol. 87: 393 (1969).

    PubMed  CAS  Google Scholar 

  12. Sandhoff, K., Andreae, U., and Jatzkewitz, H., Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs, Life Sci. 7: 283 (1968).

    PubMed  CAS  Google Scholar 

  13. Landing, B. H., Silverman, F. N., Craig, M. M., Jacoby, M. D., Lahey, M. E., and Chadwick, D. L., Familial neurovisceral lipidosis, Am. J. Dis. Child. 108: 503 (1964).

    PubMed  CAS  Google Scholar 

  14. O’Brien, J. S., GM1-gangliosidoses, in: The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., McGraw-Hill, New York, 3rd ed., pp. 639–662 (1972).

    Google Scholar 

  15. Derry, D. M., Fawcett, J. S., Andermann, F., and Wolfe, L. S., Late infantile systemic lipidosis. Major monosialogangliosidosis, delineation of two types, Neurology 18: 340 (1968).

    PubMed  CAS  Google Scholar 

  16. Pilz, H., Müller, D., Sandhoff, K., and ter Meulen, V., Tay-Sachssche Krankheit mit Hexosaminidase-Defekt. Klinische, morphologische und biochemische Befunde bei einem Fall mit viszeraler Speicherung von Nierenglobosid, Dtsch. Med. Wochenschr. 39: 1833 (1968).

    Google Scholar 

  17. Klenk, E., The pathological chemistry of the developing brain, in: Biochemistry of the Developing Nervous System, E. Waeisch, ed., Academic Press, New York, pp. 397–409 (1955).

    Google Scholar 

  18. Svennerholm, L., The nature of the gangliosides in Tay-Sachs disease, in: Cerebral Lipidosis, L. van Bogaert, J. N. Cumings, and A. Lowenthal, eds., Blackwell, Oxford, pp. 139–145 (1957).

    Google Scholar 

  19. Saifer, A. and Wishnow, D. E., Disturbances of lipid metabolism and their relationship to the lipidoses, in: Handbook of Clinical Neurology, P. J. Vinken, and G. W. Bruyn, eds., North-Holland, Amsterdam, Vol. 10, pp. 265–324 (1970).

    Google Scholar 

  20. King, J., Practical Clinical Enzymology, Van Nostrand, Princeton, N. J. (1965).

    Google Scholar 

  21. Svennerholm, L., The chemical structure of normal human brain and Tay-Sachs gangliosides, Biochem. Biophys. Res. Commun. 9: 436 (1962).

    PubMed  CAS  Google Scholar 

  22. Svennerholm, L., Chromatographic separation of human brain gangliosides, J. Neurochem. 10: 613 (1963).

    PubMed  CAS  Google Scholar 

  23. Saifer, A., The biochemistry of Tay-Sachs disease, in: Tay-Sachs Disease, B. W. Volk, ed., Grüne & Stratton, New York, pp. 97–103 (1964).

    Google Scholar 

  24. Aronson, S. M., Saifer, A., Perle, G., and Volk, B. W., Studies on enzyme alterations in the infantile sphingolipidoses. Correlation with pathologic changes, Am. J. Clin. Nutr. 9: 103 (1961).

    PubMed  CAS  Google Scholar 

  25. Aronson, S. M., Saifer, A., Kanof, A., and Volk, B. W., Progression of amaurotic family idiocy as reflected by serum and cerebrospinal fluid changes, Am. J. Med. 24: 390 (1958).

    PubMed  CAS  Google Scholar 

  26. Siegel, A. and Bing, R. J., Plasma enzyme activity in myocardial infarction in dog and man, Proc. Soc. Exp. Biol. Med. 91: 604 (1956).

    PubMed  CAS  Google Scholar 

  27. Saifer, A., Schneck, L., Perle, G., and Volk, B. W., Lactate dehydrogenase isoenzyme distribution in the cerebral sphingolipidoses and other neurological disorders, Neurology 19: 147 (1969).

    PubMed  CAS  Google Scholar 

  28. Aronson, S. M., Perle, G., Saifer, A., and Volk, B. W., Biochemical identification of the carrier state in Tay-Sachs disease, Proc. Soc. Exp. Biol. Med. 111: 664 (1962).

    CAS  Google Scholar 

  29. Schneck, L., Perle, G., and Volk, B. W., Fructose tolerance in Tay-Sachs’ disease, Pediatrics 36: 272 (1965).

    PubMed  CAS  Google Scholar 

  30. Klenk, E., Beiträge zur Chemie der Lipoidosen, Niemann-Pick’sche Krankheit und amaurotische Idiotie, Hoppe-Seyler’s Z. Physiol. Chem. 262: 128 (1939–1940).

    Google Scholar 

  31. Klenk, E., Über die Ganglioside des Gehirns bei der infantilen amaurotischen Idiotie von Typus Tay-Sachs, Ber. Dtsch. Chem. Ges. 75: 1632 (1942).

    Google Scholar 

  32. Svennerholm, L., The gangliosides, J. Lipid Res. 5: 145 (1964).

    PubMed  CAS  Google Scholar 

  33. Gatt, S. and Berman, E. R., Studies on brain lipids in Tay-Sachs disease. I. Isolation of two sialic acid-free glycolipids, Neurochem. 10: 43 (1963).

    CAS  Google Scholar 

  34. Suzuki, K., Ganglioside patterns of normal and pathological brain, in: Inborn Disorders of Sphingolipid Metabolism, S. M. Aronson, and B. W. Volk, eds., Pergamon Press, New York, pp. 215–230 (1967).

    Google Scholar 

  35. Klenk, E., Liedtke, U., and Gielen, W., Das Gangliosid des Gehirns bei der infantilen amaurotischen Idiotie vom Typ Tay-Sachs, Hoppe-Seyler’s Z. Physiol. Chem. 334: 186 (1963).

    PubMed  CAS  Google Scholar 

  36. Makita, A. and Yamakawa, T., The glycolipids of the brain of Tay-Sachs disease. The chemical structures of a globoside and main ganglioside, Jpn. J. Exp. Med. 33: 361 (1963).

    PubMed  CAS  Google Scholar 

  37. Ledeen, R., The chemistry of gangliosides: A review, J. Am. Oil Chem. Soc. 43: 57 (1966).

    PubMed  CAS  Google Scholar 

  38. Wiegandt, H., Ganglioside, Ergeh. Physiol. Biol. Chem. Exp. Pharmakol. 57: 190 (1966).

    CAS  Google Scholar 

  39. Volk, B. W., ed., Tay-Sachs’ Disease, Grune & Stratton, New York, (1964).

    Google Scholar 

  40. Stanbury, J. B., Wyngaarden, J. B., and Fredrickson, D. S., eds., The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, Chaps. 1 and 2 (1972).

    Google Scholar 

  41. Suzuki, K., Suzuki, K., and Kamoshita, S., Chemical pathology of GM1-gangliosidosis (generalzied gangliosidosis), J. Neuropathol. Exp. Neurol. 28: 25 (1969).

    PubMed  CAS  Google Scholar 

  42. Kolodny, E. H., Brady, R. O., and Volk, B. W., Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease, Biochem. Biophys. Res. Commun. 37: 526 (1969).

    PubMed  CAS  Google Scholar 

  43. Okada, S. and O’Brien, J., Tay-Sachs disease: Generalized absence of a β-D-N-acetylhexosaminidase component, Science 165: 698 (1969).

    PubMed  CAS  Google Scholar 

  44. Robinson, D. and Stirling, J. L., N-Acetyl-β-glucosaminidases in human spleen, Biochem. J. 107: 321 (1968).

    PubMed  CAS  Google Scholar 

  45. Sandhoff, K., Variation of β-N-acetylhexosaminidase-pattern in Tay-Sachs disease, FEBS Lett. 4: 351 (1969).

    PubMed  CAS  Google Scholar 

  46. Hultberg, B., N-acetylhexosaminidase activities in Tay-Sachs disease, Lancet 2: 1195 (1969).

    PubMed  CAS  Google Scholar 

  47. Helferich, B. and Iloff, A., Über Emulsion. XIII. Darstellung und fermentative Spaltung von Glykosiden des N-Acetyl-glucosamins und der 2-Desoxyglucose, Hoppe-Seyler’s Z. Physiol. Chem. 221: 252 (1933).

    CAS  Google Scholar 

  48. Caygill, J. C. and Jevons, F. R., β-Glucosaminidase activity in human synovial fluid, blood, plasma and leucocytes, Clin. Chim. Acta 13: 61 (1966).

    PubMed  CAS  Google Scholar 

  49. Furiya, S. and Fukuda, A., Estimation of serum β-acetylaminodeoxyglucosidase, J. Biochem. 54: 398 (1963).

    PubMed  CAS  Google Scholar 

  50. Leaback, D. H. and Walker, P. G., Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-β-glucosaminidase, Biochem. J. 78: 151 (1961).

    PubMed  CAS  Google Scholar 

  51. Woollen, J. W. and Turner, P., Plasma N-acetyl-β-glucosaminidase and β-glucuronidase in health and disease, Clin. Chim. Acta 12: 671 (1965).

    PubMed  CAS  Google Scholar 

  52. Price, R. G., Dance, N., Richards, B., and Cattell, W. R., The excretion of N-acetyl-β-glucosaminidase and β-galactosidase following surgery to the kidney, Clin. Chim. Acta 27: 65 (1970).

    PubMed  CAS  Google Scholar 

  53. Sandman, R., Margules, R. M. and Kountz, S. L., Urinary lysosomal glycosidases after renal allotransplantation: Correlation of enzyme excretion with allograft rejection and ischemia, Clin. Chim. Acta 45: 349 (1973).

    PubMed  CAS  Google Scholar 

  54. Walker, P. G., Woollen, J. W., and Heyworth, R., Studies on glucosaminidase. 5. Kidney N-acetyl-β-glucosaminidase and N-acetyl-β-galactosaminidase, Biochem. J. 79: 288 (1961).

    PubMed  CAS  Google Scholar 

  55. Li, S.-C. and Li, Y.-T., Studies on the glycosidases of Jack Bean meal. 3. Crystallization and properties of β-N-acetylhexosaminidase, J. Biol. Chem. 245: 5153 (1970).

    PubMed  CAS  Google Scholar 

  56. Mega, T., Ikenaka, T., and Matsushima, Y., Studies on N-acetyl-β-D-glucosaminidase of Aspergillus oryzae, J. Biochem. 68: 109 (1970).

    PubMed  CAS  Google Scholar 

  57. Frohwein, Y. Z. and Gatt, S., Isolation of β-N-acetylhexosaminidase, β-N-acetylglu- cosaminidase, and β-N-acetylgalactosaminidase from calf brain, Biochemistry 6: 2775 (1967).

    PubMed  CAS  Google Scholar 

  58. Wetmore, S. J. and Verpoorte, J. A., The partial purification of two β-N-acetyl-D-hexosaminidases from porcine kidney, Can. J. Biochem. 50: 563 (1972).

    PubMed  CAS  Google Scholar 

  59. Verpoorte, J. A., Purification of two β-N-acetyl-D-glucosaminidases from beef spleen, J. Biol. Chem. 241: 4m (1972).

    Google Scholar 

  60. Sandhoff, K. and Wassle, W., Anreicherung und Charakterisierung zweier Formen der menschlichen N-acetyl-β-D-hexosaminidase, Hoppe-Seyler’s Z. Physiol. Chem. 352: 1119 (1971).

    PubMed  CAS  Google Scholar 

  61. Li, Y.-T., Mazzotta, M. Y., Wan, C.-C., Orth, R., and Li, S.-C., Hydrolysis of Tay-Sachs ganglioside by β-hexosaminidase A of human liver and urine, J. Biol. Chem. 248: 7512 (1973).

    PubMed  CAS  Google Scholar 

  62. Carroll, M. and Robinson, D., Immunological properties of N-acetyl-β-D-glucosaminidase of normal human liver and of GM2-gangliosidosis liver, Biochem. J. 131: 91 (1973).

    PubMed  CAS  Google Scholar 

  63. Verpoorte, J. A., Isolation and characterization of the major β-N-acetyl-D-glucosaminidase from human plasma, Biochemistry 13: 793 (1974).

    PubMed  CAS  Google Scholar 

  64. Srivastava, S. K., Awasthi, Y. C., Yoshida, A., and Beutler, E., Studies on human (β-D-N-acety Hexosaminidases. I. Purification and properties, J. Biol. Chem. 249: 2043 (1974).

    PubMed  CAS  Google Scholar 

  65. Goldstone, A., Konecny, P., and Koenig, H., Lysosomal hydrolases: Conversion of acidic to basic forms by neuraminidase, FEBS Lett. 13: 68 (1971).

    PubMed  CAS  Google Scholar 

  66. Murphy, J. V. and Craig, L., Neuraminidase-induced changes in white blood cell hexosaminidase A, Clin. Chim. Acta 42: 267 (1972).

    CAS  Google Scholar 

  67. Srivastava, S. K., Yoshida, A., Awasthi, Y. C., and Beutler, E., Studies on human β-D-N-acety Hexosaminidases. II. Kinetic and structural properties, J. Biol. Chem. 249: 2049 (1974).

    PubMed  CAS  Google Scholar 

  68. van Someren, H. and van Henegouwen, H. B., Independent loss of human hexosaminidases A and B in man-Chinese hamster somatic cell hybrids, Humangenetik 18: 171 (1973).

    PubMed  Google Scholar 

  69. Dawson, G., Propper, R. L., and Dorfman, A., Partial purification of β-N-acetylhexosaminidase A by affinity chromatography, Biochem. Biophys. Res. Commun. 54: 1102 (1973).

    PubMed  CAS  Google Scholar 

  70. Grebner, E. E. and Parikh, I., An affinity adsorbent for N-acetyl-β-hexosaminidase A, Biochim. Biophys. Acta 350: 437 (1974).

    PubMed  CAS  Google Scholar 

  71. Grebner, E. E. and Tucker, J., Human urinary N-acetyl-β-hexosaminidases, Biochim. Biophys. Acta 321: 228 (1973).

    PubMed  CAS  Google Scholar 

  72. Srivastava, S. K. and Beutler, E., Antibody against purified human hexosaminidase B cross-reacting with hexosaminidase A, Biochem. Biophys. Res. Commun. 47: 753 (1972).

    PubMed  CAS  Google Scholar 

  73. Robinson, D., and Carroll, M., Tay-Sachs disease: Interrelation of hexosaminidases A and B, Lancet 1: 322 (1972).

    PubMed  CAS  Google Scholar 

  74. Price, R. G. and Dance, N., The demonstration of multiple heat-stable forms of N-acetyl-β-glucosaminidase in normal human serum, Biochim. Biophys. Acta 271: 145 (1972).

    PubMed  CAS  Google Scholar 

  75. Srivastava, S. K. and Beutler, E., Studies on human β-D-N-acety Hexosaminidases. III. Biochemical genetics of Tay-Sachs and Sandhoff’s diseases, J. Biol. Chem. 249: 2054 (1974).

    PubMed  CAS  Google Scholar 

  76. Srivastava, S. K., and Beutler, E., Hexosaminidase-A and hexosaminidase-B: Studies in Tay-Sachs and Sandhoff’s disease, Nature (London) 241: 463 (1973).

    CAS  Google Scholar 

  77. Ford, J. R., Nunley, J. A., Li, Y.-T., Chambers, R. P., and Cohen, W., A continuously monitored spectrophotometric assay of glycosidases with nitrophenyl glycosides, Anal. Biochem. 54: 120 (1973).

    PubMed  CAS  Google Scholar 

  78. Rosenthal, A. L. and Saifer, A., Continuous UV monitoring of fluorogenic substrates. I. Kinetic analysis of N-acetyl-β-D-hexosaminidases, Anal. Biochem. 55: 85 (1973).

    PubMed  CAS  Google Scholar 

  79. Kanfer, J. N. and Spielvogel, C. H., The inhibition of β-N-acetylhexosaminidases by lactones, Biochim. Biophys. Acta 327: 405 (1973).

    PubMed  CAS  Google Scholar 

  80. Sandhoff, K., Andreae, U., and Jatzkewitz, H., Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs, Pathol. Eur. 3: 278 (1968).

    PubMed  CAS  Google Scholar 

  81. Frohwein, Y. Z. and Gatt, S., Enzymatic hydrolysis of sphingolipids. VI. Hydrolysis of ceramide glycosides by calf brain β-N-acetylhexosaminidase, Biochemistry 6: 2783 (1967).

    PubMed  CAS  Google Scholar 

  82. Dance, N., Price, R. G., Robinson, D., and Stirling, J. L., β-Galactosidase, β-glucosidase and N-acetyl-β-glucosaminidase in human kidney, Clin. Chim. Acta 24: 189 (1969).

    PubMed  CAS  Google Scholar 

  83. Robinson, D., Price, R. G., and Dance, N., Separation and properties of β-galactosidase, β-glucosidase, β-glucuronidase and N-acetyl-β-glucosaminidase from rat kidney, Biochem. J. 102: 525 (1967).

    PubMed  CAS  Google Scholar 

  84. Young, E. P., Ellis, R. B., Lake, B. D., and Patrick, A. D., Tay-Sachs disease and related disorders: Fractionation of brain N-acetyl-β-hexosaminidase on DEAE-cellulose, FEBS Lett. 9: 1 (1970).

    PubMed  CAS  Google Scholar 

  85. Robinson, D., Jordan, T. W., and Horsburgh, T., The N-acetyl-β-D-hexosaminidases of calf and human brain, J. Neurochem. 19: 1975 (1972).

    Google Scholar 

  86. Hooghwinkel, G. J. M., Veltkamp, W. A., Overdijk, B., and Lisman, J. J. W., Electrophoretic separation of β-N-acetylhexosaminidases of human and bovine brain and liver and of Tay-Sachs brain tissue, Hoppe-Seyler’s Z. Physiol. Chem. 353: 839 (1972).

    PubMed  CAS  Google Scholar 

  87. Poenaru, L. and Dreyfus, J. C., Electrophoretic study of hexosaminidases. Hexosaminidase C, Clin. Chim. Acta 43: 439 (1973).

    PubMed  CAS  Google Scholar 

  88. Hultberg, B. and Ockerman, P. A., Artificial substrates in the assay of acid glycosidases, Clin. Chim. Acta 39: 49 (1972).

    CAS  Google Scholar 

  89. Hultberg, B., Ockerman, P. A., and Norden, N. E., Isoenzymes of four acid hydrolases in human kidney and urine, Clin. Chim. Acta 52: 239 (1974).

    PubMed  CAS  Google Scholar 

  90. Kanfer, J. N. and Spielvogel, C., Hexosaminidase activity of cultured human skin fibroblasts, Biochim. Biophys. Acta 293: 203 (1973).

    PubMed  CAS  Google Scholar 

  91. Okada, S., Veath, M. L., Leroy, J., and O’Brien, J. S., Ganglioside GM2 storage diseases: Hexosaminidase deficiencies in cultured fibroblasts, Am. J. Hum. Genet. 23: 55 (1971).

    PubMed  CAS  Google Scholar 

  92. Woolen, J. and Walker, P. G., The fluorimetric estimation of N-acetyl-β-glucosamini- dase and β-galactosidase in blood plasma, Clin. Chim. Acta 12: 647 (1965).

    Google Scholar 

  93. Stirling, J. L., A new form of N-acetyl-β-glucosaminidase present in pregnancy serum, Biochem. J. 123: 11P (1971).

    PubMed  CAS  Google Scholar 

  94. O’Brien, J. S., Okada, S., Chen, A., and Fillerup, D. L., Tay-Sachs disease: Detection of heterozygotes and homozygotes by serum hexosaminidase assay, New Engl. J. Med. 283: 15 (1970).

    PubMed  Google Scholar 

  95. Walker, P. G., Woollen, M. E., and Pugh, D., N-Acetyl-β-glucosaminidase activity in serum during pregnancy, J. Clin. Pathol. 13: 353 (1960).

    PubMed  CAS  Google Scholar 

  96. Stirling, J. L., Separation and characterisation of N-acetyl-β-glucosaminidases A and P from maternal serum, Biochim. Biophys. Acta 271: 154 (1972).

    PubMed  CAS  Google Scholar 

  97. Lowden, J. A. and LaRamee, M. A., Problems in prenatal diagnosis using sphingolipid hydrolase assays, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 257–267 (1972).

    Google Scholar 

  98. Huddleston, J. F., Lee, G., and Robinson, J. C., Electrophoretic characterization of glucose dehydrogenase, β-glucuronidase, and N-acetyl-β-glucosaminidase from placenta and gestational serum, Am. J. Obstet. Gynecol. 109: 1017 (1971).

    PubMed  CAS  Google Scholar 

  99. Hayase, K. and Kritchevsky, D., Separation and comparison of isoenzymes of N-acetyl-beta-D-hexosaminidase of pregnancy serum by Polyacrylamide gel electrofocusing, Clin. Chim. Acta 46: 455 (1973).

    PubMed  CAS  Google Scholar 

  100. Hayase, K., Reisher, S. R., and Kritchevsky, D., Microheterogeneity of N-acetyl-β-D-hexosaminidase of bull epididymis, Proc. Soc. Exp. Biol. Med. 142: 466 (1973).

    PubMed  CAS  Google Scholar 

  101. Williamson, A. R., Salaman, M. R., and Kreth, H. W., Microheterogeneity and allomorphism of proteins, Ann. N. Y. Acad. Sci. 209: 210 (1973).

    PubMed  CAS  Google Scholar 

  102. Ikonne, J. U. and Ellis, R. B., N-Acetyl-β-D-hexosaminidase component A. Different forms in human tissues and fluids, Biochem. J. 135: 457 (1973).

    PubMed  CAS  Google Scholar 

  103. Schneck, L., Friedland, J., Valenti, C., Adachi, M., Amsterdam, D., and Volk, B. W., Prenatal diagnosis of Tay-Sachs disease, Lancet 1: 582 (1970).

    PubMed  CAS  Google Scholar 

  104. Murphy, J. V., Hexosaminidases in cell-free amniotic fluid, Life Sci. 11: 309 (1972).

    CAS  Google Scholar 

  105. Friedland, J., Schneck, L., Saifer, A., Pourfar, M., and Volk, B. W., Identification of Tay-Sachs disease carriers by acrylamide gel electrophoresis, Clin. Chim. Acta 28: 397 (1970).

    PubMed  CAS  Google Scholar 

  106. Murphy, J. V. and Craig, L., Effect of human cerebral neuraminidase on hexosaminidase A, Clin. Chim. Acta 51: 67 (1974).

    PubMed  CAS  Google Scholar 

  107. Leibovitz, Z. and Gatt, S., Enzymatic hydrolysis of sphingolipids. VII. Hydrolysis of gangliosides by a neuraminidase from calf brain, Biochim. Biophys. Acta 152: 136 (1968).

    PubMed  CAS  Google Scholar 

  108. Tallman, J. F., Johnson, W. G., and Brady, R. O., The metabolism of Tay-Sachs ganglioside: Catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue, J. Clin. Invest. 51: 2339 (1972).

    PubMed  CAS  Google Scholar 

  109. Tallman, J. F. and Brady, R. O., The catabolism of Tay-Sachs ganglioside in rat brain lysosomes, J. Biol. Chem. 247: 7570 (1972).

    Google Scholar 

  110. Sandhoff, K., The hydrolysis of Tay-Sachs ganglioside (TSG) by human N-acetyl-β-D-hexosaminidase A, FEBS Lett. 11: 342 (1970).

    PubMed  CAS  Google Scholar 

  111. Sandhoff, K., Harzer, K., Wässle, W., and Jatzkewitz, H., Enzyme alterations and lipid storage in three variants of Tay-Sachs disease, J. Neurochem. 18: 2469 (1971).

    PubMed  CAS  Google Scholar 

  112. Sandhoff, K. and Jatzkewitz, H., The chemical pathology of Tay-Sachs disease, in, Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 305–319 (1972).

    Google Scholar 

  113. Wenger, D. A., Okada, S., and O’Brien, J. S., Studies on the substrate specificity of hexosaminidase A and B from liver, Arch. Biochem. Biophys. 153: 116 (1972).

    PubMed  CAS  Google Scholar 

  114. Brady, R. O., The sphingolipidoses, New Engl. J. Med. 275: 312 (1966).

    PubMed  CAS  Google Scholar 

  115. Kolodny, E. H., Sandhoff’s disease: Studies on the enzyme defect in homozygotes and detection of heterozygotes, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 321–341 (1972).

    Google Scholar 

  116. Desnick, R. J., Snyder, P. D., Desnick, S. J., Krivit, W., and Sharp, H. L., Sandhoff’s disease: Ultrastructural and biochemical studies, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 351–371 (1972).

    Google Scholar 

  117. Tateson, R. and Bain, A. D., GM2 gangliosidoses: Consideration of the genetic defects, Lancet 2: 612 (1971).

    PubMed  CAS  Google Scholar 

  118. Brady, R. O., Tallman, J. F., Johnson, W. G., and Quirk, J. M., An investigation of the metabolism of Tay-Sachs ganglioside specifically labeled in critical portions of the molecule, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 277–285 (1972).

    Google Scholar 

  119. Snyder, P. D., Jr., Krivit, W., and Sweeley, C. C., Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain, J. Lipid Res. 13: 128 (1972).

    PubMed  CAS  Google Scholar 

  120. Suzuki, Y., Jacob, J. C., Suzuki, K., Kutty, K. M., and Suzuki, K., GM2-gangliosidosis with total hexosaminidase deficiency, Neurology 21: 313 (1971).

    PubMed  CAS  Google Scholar 

  121. Yabuuchi, H., Sumi, K., Okada, S., and Yutaka, T., Chromatograpic study of serum hexosaminidase in normal and GM2-gangliosidosis, Clin. Chim. Acta 53: 85 (1974).

    PubMed  CAS  Google Scholar 

  122. O’Brien, J. S., Okada, S., Ho, M. W., Fillerup, D. L., Veath, M. L., and Adams, K., Ganglioside storage diseases, Fed. Proc. Fed. Am. Soc. Exp. Biol. 30: 956 (1971).

    Google Scholar 

  123. Padeh, B. and Navon, R., Diagnosis of Tay-Sachs disease by hexosaminidase activity in leukocytes and amniotic cells, Israel J. Med. Sci. 7: 259 (1971).

    PubMed  CAS  Google Scholar 

  124. Suzuki, Y., Berman, P. H., and Suzuki, K., Detection of Tay-Sachs disease heterozygotes by assay of hexosaminidase A in serum and leukocytes, J. Pediatr. 78: 643 (1971).

    PubMed  CAS  Google Scholar 

  125. O’Brien, J. S., Ganglioside storage diseases, in: Advances in Human Genetics, H. Harris and K. Hirschhorn, eds., Plenum Press, New York, Vol. 3, pp. 39–98 (1972).

    Google Scholar 

  126. Navon, R., and Padeh, B., Urinary test for identification of Tay-Sachs genotypes, J. Pediatr. 80: 1026 (1972).

    PubMed  CAS  Google Scholar 

  127. Carmody, P. J., Rattazzi, M. C., and Davidson, R. G., Tay-Sachs disease—The use of tears for the detection of heterozygotes, New Engl. J. Med. 289: 1072 (1973).

    PubMed  CAS  Google Scholar 

  128. Kaback, M. M.: Thermal fractionation of serum hexosaminidases: Applications to heterozygote detection and diagnosis of Tay-Sachs disease, in: Methods of Enzymology, V. Ginsburg, ed., Academic Press, New York, Vol. 28, part B, pp. 862–867 (1973).

    Google Scholar 

  129. Saifer, A. and Rosenthal, A. L., Rapid test for the detection of Tay-Sachs disease heterozygotes and homozygotes by serum hexosaminidase assay, Clin. Chim. Acta 43: 417 (1973).

    PubMed  CAS  Google Scholar 

  130. Rattazzi, M. C. and Davidson, R. G., Prenatal detection of Tay-Sachs disease, in: Antenatal Diagnosis, A. Dorfman, ed., University of Chicago Press, Chicago, 111., pp. 207–211 (1972).

    Google Scholar 

  131. Saifer, A. and Parkhurst, G. W., N-Acetyl-β-D-hexosaminidase isoenzyme pattern in Tay-Sachs disease, Clin. Chem. 20: 881 (1974) (Abstract 139).

    Google Scholar 

  132. Kaback, M. M. and Zeiger, R. S., Heterozygote detection in Tay-Sachs disease: A pro-totype community screening program for the prevention of recessive disorders, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 613–632 (1972).

    Google Scholar 

  133. Lowden, J. A., Skomorowski, M. A., Henderson, F., and Kaback, M., Automated assay of hexosaminidases in serum, Clin. Chem. 19: 1345 (1973).

    PubMed  CAS  Google Scholar 

  134. Delvin, E., Pottier, A., Scriver, C. R., and Gold, R. J. M., The application of an automated hexosaminidase assay to genetic screening. Clin. Chim. Acta 53: 135 (1974).

    PubMed  CAS  Google Scholar 

  135. Saifer, A. and Perle, G., Automated determination of serum hexosaminidase A by pH inactivation for detection of Tay-Sachs disease heterozygotes, Clin. Chem. 20: 538 (1974).

    PubMed  CAS  Google Scholar 

  136. Saifer, A., Perle, G., Valenti, C., and Schneck, L., Pre- and postnatal detection of Tay-Sachs disease. A comparative study of biochemical screening methods, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 599–611 (1972).

    Google Scholar 

  137. Schneck, L., Adachi, M., and Volk, B. W., Chemical pathology of Tay-Sachs disease in the fetus, in: Sphingolipids, Sphingolipidoses and Allied Disorders, B. W. Volk and S. M. Aronson, eds., Plenum Press, New York, pp. 385–394 (1972).

    Google Scholar 

  138. Saifer, A., Schneck, L., Perle, G., Valenti, C., and Volk, B. W., Caveats of antenatal diagnosis of Tay-Sachs disease, Am. J. Obstet. Gynecol. 115: 553 (1973).

    Google Scholar 

  139. Friedland, J., Perle, G., Saifer, A., Schneck, L., and Volk, B. W., Screening for Tay-Sachs disease “in utero” using amniotic fluid, Proc. Soc. Exp. Biol. Med. 136: 1297 (1971).

    PubMed  CAS  Google Scholar 

  140. Okada, S., Veath, M. L., and O’Brien, J. S., Juvenile GM2 gangliosidosis: Partial deficiency of hexosaminidase A, J. Pediatr. 77: 1063 (1970).

    PubMed  CAS  Google Scholar 

  141. Suzuki, Y. and Suzuki, K., Partial deficiency of hexosaminidase component A in juvenile GM2-gangliosidosis, Neurology 20: 848 (1970).

    PubMed  CAS  Google Scholar 

  142. Schneck, L., Friedland, J., Pourfar, M., Saifer, A., and Volk, B. W., Hexosaminidase activities in a case of systemic GM2 gangliosidosis of the late infantile type, Proc. Soc. Exp. Biol. Med. 133: 997 (1970).

    PubMed  CAS  Google Scholar 

  143. Norman, R. N., Urich, H., Tingey, A. H., and Goodbody, R. A., Tay-Sachs disease with visceral involvement and its relationship to Niemann-Pick’s disease, J. Pathol. Bacteriol. 72: 409 (1959).

    Google Scholar 

  144. Taori, G. M., Basu, D. K., Chandi, S., Raman, P. T., Abraham, J., Leelavathy, R., and Job, C. K., GM1-gangliosidosis, J. Neurol. Sci. 21: 77 (1974).

    PubMed  CAS  Google Scholar 

  145. Wolfe, L. S., Callahan, J., Fawcett, J. S., Andermann, F., and Scriver, C., GM1-gangliosidosis without chondrodystrophy or visceromegaly: β-Galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate, Neurology 20: 23 (1970).

    PubMed  CAS  Google Scholar 

  146. Suzuki, Y., Crocker, A. C., and Suzuki, K., GM1-gangliosidosis. Correlation of clinical and biochemical data, Arch. Neurol. (Chicago) 24: 58 (1971).

    CAS  Google Scholar 

  147. Okada, S. and O’Brien, J. S., Generalized gangliosidosis: β-Galactosidase deficiency, Science 160: 1002 (1968).

    PubMed  CAS  Google Scholar 

  148. Sloan, H. R., Uhlendorf, B. W., Jacobson, C. B. and Fredrickson, D. S., β-Galactosidase in tissue culture derived from human skin and bone marrow: Enzyme defect in GM1-gangliosidosis, Pediatr. Res. 3: 532 (1969).

    PubMed  CAS  Google Scholar 

  149. Dacremont, G. and Kint, J. A., GM1-ganglioside accumulation and β-galactosidase deficiency in a case of GM1-gangliosidosis (Landing disease), Clin. Chim. Acta 21: 421 (1968).

    PubMed  CAS  Google Scholar 

  150. Van Hoof, F. and Hers, H. G., The abnormalities of lysosomal enzymes in mucopolysaccharidoses, Eur. J. Biochem. 7: 34 (1968).

    PubMed  Google Scholar 

  151. MacBrinn, M. C., Okada, S., Ho, M. W., Hu, C. C., and O’Brien, J. S., Generalized gangliosidoses. Impaired cleavage of galactose from a mucopolysaccharide and a glycoprotein, Science 163: 946 (1969).

    PubMed  CAS  Google Scholar 

  152. Brady, R. O., O’Brien, J. S., Bradley, R. M., and Gal, A. E., Sphingolipid hydrolases in brain tissue of patients with generalized gangliosidosis, Biochim. Biophys. Acta 210: 193 (1970).

    PubMed  CAS  Google Scholar 

  153. Suzuki, Y. and Suzuki, K., Glycosphingolipid β-galactosidases. IV. Electrofocusing characterization in GM1-gangliosidosis, J. Biol. Chem. 249: 2113 (1974).

    PubMed  CAS  Google Scholar 

  154. Singer, H. S. and Schafer, I. A., White cell β-galactosidase activity, New Engl. J. Med. 282: 571 (1970).

    PubMed  CAS  Google Scholar 

  155. Thomas, G. H., β-D-Galactosidase in human urine: Deficiency in generalized gangliosidosis, J. Lab. Clin. Med. 74: 725 (1969).

    PubMed  CAS  Google Scholar 

  156. Hultberg, B. and Ockerman, P. A., Artificial substrates in the assay of acid glycosidases, Clin. Chim. Acta 39: 49 (1972).

    CAS  Google Scholar 

  157. Suzuki, Y. and Suzuki, K., Glycosphingolipid β-galactosidases. I. Standard assay procedures and characterization by electrofocusing and gel filtration of the enzymes in normal human liver, J. Biol. Chem. 249: 2098 (1974).

    PubMed  CAS  Google Scholar 

  158. Ho, M. W. and O’Brien, J. S., Stimulation of acid β-galactosidase activity by chloride ions, Clin. Chim. Acta 30: 531 (1970).

    PubMed  CAS  Google Scholar 

  159. Ho, M. W. and O’Brien, J. S., Hurler’s syndrome: Deficiency of a specific beta-galactosidase isoenzyme, Science 165: 611 (1969).

    CAS  Google Scholar 

  160. Pinsky, L., Powell, E., and Callahan, J., GM1-gangliosidosis types 1 and 2: Enzymatic differences in cultured fibroblasts, Nature (London) 228: 1093 (1970).

    CAS  Google Scholar 

  161. Ho, M. W. and O’Brien, J. S., Differential effect of chloride ions on β-galactosidase isoenzymes: A method for separate assay, Clin. Chim. Acta 32: 443 (1971).

    PubMed  CAS  Google Scholar 

  162. O’Brien, J. S., Five gangliosidoses, Lancet 2: 805 (1969).

    PubMed  Google Scholar 

  163. Hultberg, B., Ockerman, P.-A., and Dahlqvist, A., Gargoylism: Hydrolysis of β-galactosides and tissue accumulation of galactose- and mannose-containing compounds, J. Clin. Invest. 49: 216 (1970).

    PubMed  CAS  Google Scholar 

  164. Singer, H. S. and Schafer, I. A., Clinical and enzymatic variations in GM1 generalized gangliosidosis, Am. J. Hum. Genet. 24: 454 (1972).

    PubMed  CAS  Google Scholar 

  165. Navon, R., Padeh, B., and Adam, A., Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am. J. Hum. Genet. 25: 287 (1973).

    PubMed  CAS  Google Scholar 

  166. Tallman, J. F., Brady, R. O., Quirk, J. M., Villalba, M., and Gal, A. E., Isolation and relationship of human hexosaminidases, J. Biol. Chem. 249: 3489 (1974).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Plenum Press, New York

About this chapter

Cite this chapter

Saifer, A. (1975). Enzymes. In: Volk, B.W., Schneck, L. (eds) The Gangliosidoses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8726-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-8726-2_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-8728-6

  • Online ISBN: 978-1-4615-8726-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics